Antibiotic Treatment for Infected Thumb Laceration
For an infected thumb laceration, treat with amoxicillin-clavulanate 875/125 mg twice daily orally, or if MRSA is suspected based on local resistance patterns or clinical severity, use trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily or clindamycin 300-400 mg four times daily orally.
Treatment Algorithm
Step 1: Assess Infection Severity and Likely Pathogens
The most common pathogens in hand lacerations are Staphylococcus aureus and beta-hemolytic group A streptococci 1, 2. Your antibiotic choice depends on:
Mechanism of injury:
- Animal bite (cat/dog): Pasteurella species require beta-lactam/beta-lactamase inhibitor coverage 2
- Human bite/"fight-bite": Eikenella corrodens and risk of joint involvement 2
- Aquatic exposure: Requires coverage for Vibrio, Aeromonas, and Pseudomonas species 3
- Standard laceration: S. aureus and Streptococcus pyogenes 1
MRSA risk factors: Consider local resistance patterns, previous MRSA infection, or systemic signs (fever, spreading erythema, lymphangitis)
Step 2: Choose Appropriate Antibiotic and Dose
For standard infected lacerations (MSSA coverage):
- First-line: Amoxicillin-clavulanate 875/125 mg twice daily orally 1
- Alternative: Cephalexin 500 mg four times daily orally 1
- Penicillin allergy: Clindamycin 300-400 mg four times daily orally 1
For suspected MRSA:
- First-line: Trimethoprim-sulfamethoxazole 1-2 double-strength tablets twice daily orally 1
- Alternative: Clindamycin 300-450 mg four times daily orally 1
- Alternative: Doxycycline 100 mg twice daily orally 1
For bite wounds:
- Amoxicillin-clavulanate 875/125 mg twice daily orally (covers Pasteurella, Eikenella, and typical pathogens) 2
For aquatic-related wounds:
- Doxycycline 100 mg twice daily PLUS ciprofloxacin 500-750 mg twice daily (or levofloxacin 500-750 mg daily) 3
Step 3: Duration of Therapy
- Standard soft tissue infection: 5-7 days of oral antibiotics
- More severe infections or joint involvement: Consider 6 weeks of therapy as recommended for hand joint infections 4
- Initial IV therapy: Reserve for systemic toxicity (SIRS criteria: fever >38°C or <36°C, tachycardia >90 bpm, tachypnea >24/min, WBC >12,000 or <4,000) 1
Step 4: When IV Therapy is Needed
If the patient has systemic signs or severe local infection requiring hospitalization:
For MSSA:
For MRSA:
- Vancomycin 30 mg/kg/day in 2 divided doses IV (15 mg/kg every 12 hours) 1
- Linezolid 600 mg every 12 hours IV 1
Critical Caveats
Prophylactic antibiotics are NOT indicated for simple lacerations. Recent high-quality evidence shows that prophylactic antibiotics after uncomplicated upper-extremity lacerations do not reduce infection rates and may paradoxically be associated with increased infection odds 5. The overall infection rate after acute laceration repair is only 2.1% 5, and routine antimicrobial treatment is discouraged for clean wounds 6.
However, once infection is established (erythema, warmth, purulence, pain), antibiotics are clearly indicated as part of treatment 1.
Surgical management is paramount. If there is purulent drainage, abscess formation, or deep space involvement, surgical debridement takes priority over antibiotics alone 4, 2. The three principles of hand infection management are: surgical treatment, appropriate antimicrobials, and early physiotherapy 2.
Watch for necrotizing infection. Severe pain disproportionate to findings, rapid progression, systemic toxicity, or crepitus warrant immediate surgical consultation and broad-spectrum IV antibiotics 1.